Translational Development Acquisition Corp. filed a Form S-1 registration statement for an initial public offering on 2024-10-22. It describes itself as a blank check company. It has amended it 2 times. It filed its final prospectus on 2024-12-23. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our units have been approved for listing on the Nasdaq Global Market, or Nasdaq, under the symbol “TDACU,” on or promptly after the date of this prospectus.From the 424B4 filed 2024-12-23
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-10-22 | Registration statement filed | S-1 |
| 2024-11-20 | Registration statement amended | S-1/A |
| 2024-12-19 | Registration statement amended | S-1/A |
| 2024-12-23 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Translational Development Acquisition Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.